Currency in USD
| Earnings estimate | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | 0.84 | 1.05 | 3.64 | 3.92 |
| Low estimate | 0.84 | 1.05 | 3.62 | 3.88 |
| High estimate | 0.84 | 1.05 | 3.67 | 3.97 |
| Year ago EPS | 0.87 | 1.1 | 3.44 | 3.64 |
| Revenue estimate | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
|---|
| No. of analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 8.47B | 9.51B | 36B | 38.46B |
| Low estimate | 8.31B | 9.45B | 35.62B | 37.83B |
| High estimate | 8.62B | 9.57B | 36.51B | 39.29B |
| Year ago sales | 8.7B | 8.24B | 36.1B | 36B |
| Sales growth (year/est) | -2.70% | 15.30% | -0.30% | 6.90% |
| Earnings history | 29/06/2022 | 29/09/2022 | 30/12/2022 | 30/03/2023 |
|---|
| Est. EPS | 0.73 | 0.96 | 0.5 | 0.82 |
| Actual EPS | 0.87 | 1.1 | 0.6 | 0.9 |
| Difference | 0.14 | 0.14 | 0.1 | 0.08 |
| Surprise % | 19.20% | 14.60% | 20.00% | 9.80% |
| EPS trend | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
|---|
| Current estimate | 0.84 | 1.05 | 3.64 | 3.92 |
| 7 days ago | 0.84 | 1.05 | 3.64 | 3.92 |
| 30 days ago | 0.84 | 1.05 | 3.7 | 3.95 |
| 60 days ago | 0.9 | 1.06 | 3.66 | 3.94 |
| 90 days ago | 0.93 | 1.09 | 3.7 | 3.97 |
| EPS revisions | Current qtr. (Jun 2023) | Next qtr. (Sep 2023) | Current year (2023) | Next year (2024) |
|---|
| Up last 7 days | N/A | N/A | 1 | 1 |
| Up last 30 days | N/A | N/A | 1 | 1 |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | GSK | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | -3.40% | N/A | N/A | N/A |
| Next qtr. | -4.50% | N/A | N/A | N/A |
| Current year | 5.80% | N/A | N/A | N/A |
| Next year | 7.70% | N/A | N/A | N/A |
| Next 5 years (per annum) | 5.00% | N/A | N/A | N/A |
| Past 5 years (per annum) | -2.63% | N/A | N/A | N/A |
